Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian B Filion

Showing results (131-140 of 304) with videos related to

Pageof 31
Sort By:
Pharmacoepidemiology and Drug Safety|August 18, 2024
Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta-AnalysisShahrzad Salmasi, Samuel Igweokpala, Antonios Douros, et al.
Diabetes Care|December 16, 2022
Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort StudyJenny Dimakos, Ying Cui, Robert W Platt, et al.
The American Journal of Cardiology|April 28, 2012
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillationCorey S Miller, Sonia M Grandi, Avi Shimony, et al.
Journal of the American Heart Association|February 24, 2016
Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsLee H Sterling, Sarah B Windle, Kristian B Filion, et al.
Clinical Pharmacology and Therapeutics|March 3, 2022
Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational StudiesNehal Islam, Henok T Ayele, Oriana H Y Yu, et al.
British Journal of Clinical Pharmacology|November 29, 2025
Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort studyFabian Maximilian Meinert, Jenny Dimakos, Ying Cui, et al.
The American Journal of Medicine|December 16, 2025
Efficacy and safety of varenicline for vaping cessation: A systematic review and meta-analysis of randomized controlled trialsTamila Varyvoda, Tetiana Zolotarova, Areesha Moiz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 2, 2025
Gestational diabetes mellitus and subsequent cardiovascular disease in a period of rising diagnoses: Cohort studyAzar Mehrabadi, Ya-Hui Yu, Sonia M Grandi, et al.
Thrombosis Research|March 29, 2024
Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort studyAntonios Douros, Ying Cui, Robert W Platt, et al.
Diabetes, Obesity & Metabolism|November 30, 2023
Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studiesSamuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, et al.
Pageof 31

Showing results (131-140 of 304) with videos related to

Sort By:
Pageof 31
Pharmacoepidemiology and Drug Safety|August 18, 2024
Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta-AnalysisShahrzad Salmasi, Samuel Igweokpala, Antonios Douros, et al.
Diabetes Care|December 16, 2022
Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort StudyJenny Dimakos, Ying Cui, Robert W Platt, et al.
The American Journal of Cardiology|April 28, 2012
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillationCorey S Miller, Sonia M Grandi, Avi Shimony, et al.
Journal of the American Heart Association|February 24, 2016
Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsLee H Sterling, Sarah B Windle, Kristian B Filion, et al.
Clinical Pharmacology and Therapeutics|March 3, 2022
Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational StudiesNehal Islam, Henok T Ayele, Oriana H Y Yu, et al.
British Journal of Clinical Pharmacology|November 29, 2025
Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort studyFabian Maximilian Meinert, Jenny Dimakos, Ying Cui, et al.
The American Journal of Medicine|December 16, 2025
Efficacy and safety of varenicline for vaping cessation: A systematic review and meta-analysis of randomized controlled trialsTamila Varyvoda, Tetiana Zolotarova, Areesha Moiz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 2, 2025
Gestational diabetes mellitus and subsequent cardiovascular disease in a period of rising diagnoses: Cohort studyAzar Mehrabadi, Ya-Hui Yu, Sonia M Grandi, et al.
Thrombosis Research|March 29, 2024
Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort studyAntonios Douros, Ying Cui, Robert W Platt, et al.
Diabetes, Obesity & Metabolism|November 30, 2023
Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studiesSamuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, et al.
Pageof 31